Gloom and Doom Meeting of docs Turns Hopeful When Patient Offers Health Reform Proposal
In Brief: Bresnick Directs Norris Cotton Cancer Center; FASEB Honors Kirschstein; Van Nevel’s 2th Year
Bosnian Research Trying To Leave, Asks For More Calls
ACS Urges Practice Of Insurance Exclusion End Under Reform
Epstein Petition Seeks Broder’s Removal As NCI Director
NIH Should Review CRADA Pricing, Wyden Write to Shalala
IOM Selects Advisors To Defense Department
“Alternative” Is Misleading Term, President’s Cancer Panel Writes To Healy
FDA Policy On Support Of Medical Education Near Final Form
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Anthony Letai pledges to ensure stability for extramural and intramural cancer science
